São Paulo, November 2021 – Eurofarma, the pharmaceutical company that invests the most in innovation in Brazil, was chosen as Company of the Year, Americas in the 8th edition of the Pharma Intelligence Global Generics & Biosimilars Awards for its innovative e-commerce with price comparison project. The winners were announced in a ceremony in Firenze, Italy, on Wednesday (11/10). This is the third consecutive time that the company has won this recognition.

The Global Generics & Biosimilars Awards acknowledges companies in 14 categories, including business development initiatives such as product innovation, smart licensing agreements, industrial partnerships and CSR, and also gives special recognition to the company of the year in the Americas, Europe, the Middle East and Africa, and Asia/Pacific, among other awards.

The winning case

Launched in late 2020, the e-commerce platform included on Eurofarma’s website makes the consumer’s journey easier with its innovative price comparison service and the offer of more than 450 generic, prescription, and non-prescription drugs available in more than 30 drugstores and pharmacies. When choosing the desired option, consumers are automatically directed to the page to complete the purchase process.

The initiative is in line with the company’s essence of offering access to the population and creating another connection point between the company and consumers. The platform was made possible through the support of Intellibrand, a startup specializing in data intelligence solutions for more efficient management and one of the companies accelerated by Eurofarma Synapsis, Eurofarma’s open innovation program.

In addition to the winning project, Eurofarma was also a finalist in the following categories:

• Value Added Medicine Initiative of the Year, with the case on the Bicerto IV drug;
• Intellectual Property Strategy of the Year, with its Patent Incentives Policy; and
• Acquisition of the Year, with the case of the purchase of Takeda’s portfolio for Latin America.

Click here to learn more about the award.

About Eurofarma Group 

As the first multinational pharmaceutical enterprise with 100% Brazilian capital, the Eurofarma Group has been operating in the pharmaceutical industry since its establishment in 1972, producing and marketing innovative healthcare products and services to improve people’s quality of life. A very diversified company, Eurofarma operates in all major segments, such as Prescription, Non-Prescription, Generic, Hospital, and Oncology. In Brazil alone, it offers more than 430 products in over 1,000 SKUs, serves all medical specialties, and covers upwards of 200 therapeutic classes, accounting for 80% of the total market.

The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in six more Latin American countries. Reported net sales totaled BRL 5.7 billion in 2020 and the Group employs over 7,600 people.

Eurofarma in social media
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma | Twitter: @eurofarma
YouTube: @eurofarmalab